Industry Standard Research
Toggle navigation
Register
Log In
Search for:
Reports
Full Report List
Manufacturing Reports
Service Provider Quality Benchmarking Reports
Trends & Technology Reports
Clinical Trial Recruitment & Retention Reports
Commercialization Reports
Department Models & Structures Reports
Biosimilars & Biologics Reports
Library Access Subscription
Custom Research
Free Resources
Core Industry Metrics
Infographics
White Papers
Industry Statistics
About
ISR Health Panel
Our Customers
Community Involvement
Media Center
Careers
Contact Us
Infographics
Free Resource
CRO Phase I Environment
CRO Phase II/III Environment
CRO Phase IV Environment
The Ideal vs. Non-Ideal Provider
2017 Clinical Development and Manufacturing Year in Review
Preferred Providers
CRO Consolidation & Employee Distribution
2016 Clinical Development and Manufacturing Year-In-Review
mHealth Technologies
Tech + Patient Recruitment
16 Years of CMO M&A
2015 Clinical Development and Manufacturing Year in Review
A History of Clinical Development Outsourcing
The World of Drug Development Trends
eClinical Trends, Tips, and Technology
The Future of Clinical Development Outsourcing
Orphan Drug 101
Ovarian Cancer Profile
CRO Capital Market
2014 Clinical Development Year in Review
The Evolution of Risk-Based Monitoring
Thyroid Cancer
Bladder Cancer: profile and drug development
Clinical development activity in perspective
Lung Cancer
Living with Severe Headaches: Symptoms, Triggers, and Unmet Needs
Brain Cancer (Glioblastoma Multiforme): Profile & Drug Development
2013 Year in Review: Clinical Development
What does the future hold for detailing and drug reps?
The ISR Difference
Biosimilar Education
Infographic: Liver Cancer
The Landscape of the Biosimilar Market
The Bottleneck in Patient Recruitment
ISR CUSTOMERS
